Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $0 - $0
0 New
0 $0
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $56,005 - $62,516
-556 Closed
0 $0
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $60,893 - $67,253
556 New
556 $63,000
Q3 2023

Nov 06, 2023

SELL
$95.53 - $114.62 $2,579 - $3,094
-27 Reduced 2.71%
970 $94,000
Q2 2023

Jul 07, 2023

BUY
$100.78 - $112.29 $100,477 - $111,953
997 New
997 $109,000
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $4,354 - $5,041
45 Added 2.09%
2,199 $213,000
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $97,272 - $117,571
-953 Reduced 30.67%
2,154 $234,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $144,463 - $176,163
-1,267 Reduced 28.97%
3,107 $367,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $78,675 - $96,334
681 Added 18.44%
4,374 $616,000
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $288,595 - $339,717
-2,728 Reduced 42.49%
3,693 $432,000
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $14,040 - $16,541
129 Added 2.05%
6,421 $769,000
Q4 2020

Feb 10, 2021

SELL
$105.0 - $114.42 $166,950 - $181,927
-1,590 Reduced 20.17%
6,292 $688,000
Q3 2020

Nov 04, 2020

BUY
$91.64 - $111.29 $207,839 - $252,405
2,268 Added 40.4%
7,882 $855,000
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $339,281 - $434,238
4,431 Added 374.56%
5,614 $514,000
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $74,316 - $108,670
1,183 New
1,183 $93,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.